Pharmaceuticals, Biotechnology and Life Sciences
– Leverages Strata Oncology’s Proprietary Biomarker Technology to Stratify Patients – HAYWARD, Calif. and ANN ARBOR, Mich.–(BUSINESS WIRE)–Arcus Biosciences, Inc.…
– Biodistribution of RP-A501 Demonstrates High Concentration in Heart, the End-Organ Target in Danon Disease – – Phase 1 Clinical…
WATERTOWN, Mass.–(BUSINESS WIRE)–Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel tetracyclines to treat serious and…
Focusing on ‘Make Transformation Happen’, AMPLEXOR’s annual event line-up of life sciences thought leaders will present strategies and best practices…
– Ironwood launches as GI-focused healthcare company following separation of Cyclerion Therapeutics on April 1, 2019 – – First quarter…
Conference Call Scheduled Today at 8:30 a.m. ET LEXINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CNCE&src=ctag" target="_blank"gt;$CNCElt;/agt; lt;a href="https://twitter.com/hashtag/CNCE?src=hash" target="_blank"gt;#CNCElt;/agt;–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)…
Data presented during “The Role of the Tie2 Pathway in Ocular Disease” symposium at the Association for Research in Vision…
Enrolled first patient in National Cancer Institute (NCI)-sponsoredPhase 3 trial of uproleselan in older adults with previously untreatedacute myeloid leukemia (AML)
DUBLIN–(BUSINESS WIRE)–The “Kuwait Pharmaceuticals Market Outlook to 2022 – By Type of Drugs; By Channel of Distribution and By Therapeutic…
ZULRESSO™ (brexanolone) injection approved by U.S. FDA and on track for launch in late June Commercial team is launch ready;…